Target Cancer | The Vaccine That Could End Breast Cancer | TCP Ep. 62 @TargetCancer | Uploaded May 2024 | Updated October 2024, 11 hours ago.
The Vaccine That Could End Breast Cancer | TARGET: Cancer Podcast | Ep. 62
Dr. Amit Kumar discusses the groundbreaking concept of a vaccine for cancer. He explains how they have identified "retired proteins" that are only produced during specific periods of life, such as lactation, and reappear when cancer cells arise. By vaccinating individuals after they no longer need these proteins, the immune system can be trained to target and destroy cancer cells. Dr. Kumar shares their progress in developing a vaccine for breast cancer and other types of cancers as well.
- - - -TimeStamps - - - -
00:00 Introduction
03:08 The retired tissue protein hypothesis
07:49 Potential use of the vaccine in a neoadjuvant setting
19:21 Grail's multi-cancer detection test
23:09 Developing a vaccine for ovarian cancer
44:13 Benefits of early detection using neoantigen-based tests
- - - -
#cancertreatment #breastcancer #cancervaccine #fightcancertogether
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. AMIT KUMAR —
Dr. Kumar has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital with OAK Investment Partners, and has been an advisor to investment funds, venture capital firms, and Fortune 500 companies. He was on the Board of Directors of Acacia Research Corporation from 2002-2008. Dr. Kumar is currently Chairman and CEO of Anixa Biosciences and he sits on the Board of other public and private companies. He has served on the Board of the American Cancer Society since 2016. He received his AB in Chemistry from Occidental College. After graduate studies at Stanford University and Caltech, he received his Ph.D. from Caltech and followed that with a post-doctoral fellowship at Harvard.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
Google Podcasts:
podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL210cnVkbmFrL2ZlZWQueG1s
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
The Vaccine That Could End Breast Cancer | TARGET: Cancer Podcast | Ep. 62
Dr. Amit Kumar discusses the groundbreaking concept of a vaccine for cancer. He explains how they have identified "retired proteins" that are only produced during specific periods of life, such as lactation, and reappear when cancer cells arise. By vaccinating individuals after they no longer need these proteins, the immune system can be trained to target and destroy cancer cells. Dr. Kumar shares their progress in developing a vaccine for breast cancer and other types of cancers as well.
- - - -TimeStamps - - - -
00:00 Introduction
03:08 The retired tissue protein hypothesis
07:49 Potential use of the vaccine in a neoadjuvant setting
19:21 Grail's multi-cancer detection test
23:09 Developing a vaccine for ovarian cancer
44:13 Benefits of early detection using neoantigen-based tests
- - - -
#cancertreatment #breastcancer #cancervaccine #fightcancertogether
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. AMIT KUMAR —
Dr. Kumar has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital with OAK Investment Partners, and has been an advisor to investment funds, venture capital firms, and Fortune 500 companies. He was on the Board of Directors of Acacia Research Corporation from 2002-2008. Dr. Kumar is currently Chairman and CEO of Anixa Biosciences and he sits on the Board of other public and private companies. He has served on the Board of the American Cancer Society since 2016. He received his AB in Chemistry from Occidental College. After graduate studies at Stanford University and Caltech, he received his Ph.D. from Caltech and followed that with a post-doctoral fellowship at Harvard.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
Google Podcasts:
podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL210cnVkbmFrL2ZlZWQueG1s
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
